rs398122403

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong

The NM_203446.3(SYNJ1):​c.656G>A​(p.Arg219Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R219W) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

SYNJ1
NM_203446.3 missense

Scores

14
4
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 7.33

Publications

81 publications found
Variant links:
Genes affected
SYNJ1 (HGNC:11503): (synaptojanin 1) This gene encodes a phosphoinositide phosphatase that regulates levels of membrane phosphatidylinositol-4,5-bisphosphate. As such, expression of this enzyme may affect synaptic transmission and membrane trafficking. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
SYNJ1 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 53
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • early-onset Parkinson disease 20
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • atypical juvenile parkinsonism
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • young-onset Parkinson disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.955
PP5
Variant 21-32695106-C-T is Pathogenic according to our data. Variant chr21-32695106-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 88844.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNJ1NM_203446.3 linkc.656G>A p.Arg219Gln missense_variant Exon 5 of 33 ENST00000674351.1 NP_982271.3 O43426-2C9JFZ1Q05CZ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNJ1ENST00000674351.1 linkc.656G>A p.Arg219Gln missense_variant Exon 5 of 33 NM_203446.3 ENSP00000501530.1 O43426-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000119
AC:
3
AN:
251466
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000116
AC:
17
AN:
1461844
Hom.:
0
Cov.:
30
AF XY:
0.00000688
AC XY:
5
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39684
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1111994
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Early-onset Parkinson disease 20 Pathogenic:2
Sep 01, 2013
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Aug 30, 2016
Institute for Human Genetics, University Medical Center Freiburg
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:case-control

This variant was found in two German patients with epilepsy early in the disease course, followed by progressive generalized dopa-responsive dystonia associated with severe action tremor of the tongue, head, and extremities in their early teen years, and cognitive deterioration. We identified compound heterozygous mutations (NP_982271.2:p.Trp171*/NP_982271.2:p.Arg258Gln) in the SYNJ1 gene, affecting the N-terminal suppressor of actin1 (SAC1)-like domain of the SYNJ1 protein. -

Early-onset Parkinson disease 20;C4479313:Developmental and epileptic encephalopathy, 53 Pathogenic:1
Jun 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 258 of the SYNJ1 protein (p.Arg258Gln). This variant is present in population databases (rs398122403, gnomAD 0.003%). This missense change has been observed in individuals with Parkinson disease (PMID: 23804563, 23804577, 24816432). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 88844). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SYNJ1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SYNJ1 function (PMID: 23804563). For these reasons, this variant has been classified as Pathogenic. -

SYNJ1-related disorder Pathogenic:1
Jun 15, 2023
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The SYNJ1 c.773G>A variant is predicted to result in the amino acid substitution p.Arg258Gln. This variant was reported in the homozygous and compound heterozygous states in multiple individuals with early onset Parkinsonism (Krebs et al. 2013. PubMed ID: 23804563; Quadri et al. 2013. PubMed ID: 23804577; Olgiati et al. 2014. PubMed ID: 24816432; Rauschendorf et al. 2016. PubMed ID: 27869329). Functional studies of this variant have provided evidence that this variant impacts protein function (Cao et al. 2017. PubMed ID: 28231468; Fasano et al. 2018. PubMed ID: 29515184). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/21-34067416-C-T). This variant is interpreted as pathogenic. -

not provided Pathogenic:1
Nov 13, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate a damaging effect with this variant resulting in reduced phosphatase activity and defects in endocytosis at the presynaptic nerve terminals (PMID: 28231468, 23804563); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28231468, 23804563, 29515184, 35810474, 23804577, 27869329, 33841314, 24816432) -

Young-onset Parkinson disease Pathogenic:1
Jan 18, 2020
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.35
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.66
.;D;.;D;D;.
Eigen
Pathogenic
0.96
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Pathogenic
1.0
D;D;D;D;D;D
M_CAP
Pathogenic
0.42
D
MetaRNN
Pathogenic
0.96
D;D;D;D;D;D
MetaSVM
Pathogenic
0.79
D
MutationAssessor
Pathogenic
4.3
H;.;.;.;.;.
PhyloP100
7.3
PrimateAI
Pathogenic
0.87
D
PROVEAN
Uncertain
-3.4
D;D;.;D;D;D
REVEL
Pathogenic
0.86
Sift
Uncertain
0.0010
D;D;.;D;D;D
Sift4G
Uncertain
0.0050
D;D;D;D;D;.
Polyphen
0.98
D;.;.;D;.;.
Vest4
0.97
MutPred
0.86
Loss of methylation at R219 (P = 0.0227);Loss of methylation at R219 (P = 0.0227);Loss of methylation at R219 (P = 0.0227);.;.;Loss of methylation at R219 (P = 0.0227);
MVP
0.86
MPC
1.6
ClinPred
1.0
D
GERP RS
5.0
gMVP
0.91
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs398122403; hg19: chr21-34067416; COSMIC: COSV59155517; COSMIC: COSV59155517; API